Ardelyx (ARDX) Assets (2013 - 2026)
Ardelyx (ARDX) reported Assets of $504.5 million for Q1 2026, up 22.99% on a YoY basis from $410.2 million in Q1 2025, and up 0.58% quarter-over-quarter from $501.6 million in Q4 2025.
Ardelyx (ARDX) Assets (2013 - 2026) Analysis & Trends
Ardelyx has reported Assets for 14 years, with the latest figure at $504.5 million in Q1 2026.
- For the quarter ending Q1 2026, Assets rose 22.99% year-over-year to $504.5 million; the trailing twelve-month figure through Mar 2026 stood at $504.5 million (up 22.99% YoY), and the FY2025 full-year result was $501.6 million, up 15.11% from the prior year.
- Assets for Q1 2026 stood at $504.5 million, up from $501.6 million in the prior quarter.
- The five-year high for Assets was $504.5 million in Q1 2026, with the low at $129.4 million in Q1 2022.
- Historically, Assets has averaged $321.7 million across 5 years, with a median of $342.4 million in 2024.
- Annual changes were most pronounced in 2022 — Assets tumbled 38.46% — and 2023, when it soared 100.02%.
- Ardelyx's Assets stood at $190.1 million in 2022, then soared by 56.57% to $297.6 million in 2023, then soared by 46.43% to $435.8 million in 2024, then advanced by 15.11% to $501.6 million in 2025, then increased by 0.58% to $504.5 million in 2026.
- The last three Assets figures came in at $504.5 million (Q1 2026), $501.6 million (Q4 2025), and $486.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 504.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 504.51 Mn |
| Dec 31, 2025 | 501.60 Mn |
| Sep 30, 2025 | 486.17 Mn |
| Jun 30, 2025 | 466.77 Mn |
| Mar 31, 2025 | 410.19 Mn |
| Dec 31, 2024 | 435.75 Mn |
| Sep 30, 2024 | 367.86 Mn |
| Jun 30, 2024 | 343.49 Mn |
| Mar 31, 2024 | 342.38 Mn |
| Dec 31, 2023 | 297.58 Mn |
| Sep 30, 2023 | 289.38 Mn |
| Jun 30, 2023 | 211.20 Mn |
| Mar 31, 2023 | 217.02 Mn |
| Dec 31, 2022 | 190.07 Mn |
| Sep 30, 2022 | 144.67 Mn |
| Jun 30, 2022 | 131.61 Mn |
| Mar 31, 2022 | 129.41 Mn |
| Dec 31, 2021 | 149.91 Mn |
| Sep 30, 2021 | 170.85 Mn |
| Jun 30, 2021 | 204.98 Mn |